Avantax Planning Partners, Inc. - SOLENO THERAPEUTICS INC ownership

SOLENO THERAPEUTICS INC's ticker is SLNO and the CUSIP is 834203200. A total of 40 filers reported holding SOLENO THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.49 and the average weighting 0.0%.

Quarter-by-quarter ownership
Avantax Planning Partners, Inc. ownership history of SOLENO THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$2,0000.0%10,7000.0%0.00%
Q1 2022$2,000
-50.0%
10,7000.0%0.00%
Q4 2021$4,000
-60.0%
10,7000.0%0.00%
Q3 2021$10,000
-16.7%
10,7000.0%0.00%
-100.0%
Q2 2021$12,000
-7.7%
10,7000.0%0.00%0.0%
Q1 2021$13,00010,7000.00%
Other shareholders
SOLENO THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Abingworth LLP 10,302,602$22,769,0006.37%
CVI Holdings, LLC 1,550,960$3,443,0001.28%
ORACLE INVESTMENT MANAGEMENT INC 3,670,384$8,148,0001.03%
Trellus Management Company, LLC 366,432$813,0000.88%
AWM Investment Company, Inc. 1,550,000$3,441,0000.60%
Samsara BioCapital, LLC 750,000$1,665,0000.54%
Nantahala Capital Management 7,426,368$16,487,0000.50%
Consonance Capital Management LP 3,040,000$6,749,0000.40%
SPHERA FUNDS MANAGEMENT LTD. 1,233,676$2,739,0000.26%
Granite Point Capital Management, L.P. 2,200,000$4,884,0000.25%
View complete list of SOLENO THERAPEUTICS INC shareholders